Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0023 | 0.0427 | 0.0364 |
Echinococcus granulosus | nervana 2 | 0.0013 | 0.0061 | 0.0044 |
Chlamydia trachomatis | 3-oxoacyl-ACP synthase | 0.0288 | 1 | 0.5 |
Echinococcus multilocularis | GPCR, family 2 | 0.0015 | 0.011 | 0.0093 |
Brugia malayi | oxidoreductase, zinc-binding dehydrogenase family protein | 0.01 | 0.3212 | 0.3168 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0015 | 0.0114 | 0.164 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.01 | 0.3212 | 0.2993 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0025 | 0.0487 | 0.0425 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0023 | 0.0427 | 0.0364 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0726 | 0.0726 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0023 | 0.0427 | 0.0364 |
Echinococcus granulosus | lamin dm0 | 0.0025 | 0.0487 | 0.0471 |
Schistosoma mansoni | 3-oxoacyl-[ACP] synthase | 0.0288 | 1 | 1 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.022 | 0.7547 | 0.7543 |
Onchocerca volvulus | 0.0045 | 0.1203 | 0.263 | |
Brugia malayi | hypothetical protein | 0.0023 | 0.0427 | 0.0365 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0427 | 0.0427 |
Brugia malayi | Protein kinase domain containing protein | 0.0022 | 0.036 | 0.0297 |
Entamoeba histolytica | protein kinase, putative | 0.0022 | 0.036 | 1 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0288 | 1 | 0.5 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.022 | 0.7547 | 0.7543 |
Loa Loa (eye worm) | intermediate filament protein | 0.0025 | 0.0487 | 0.0487 |
Trichomonas vaginalis | AGC family protein kinase | 0.0022 | 0.036 | 0.5 |
Echinococcus granulosus | 3 oxoacyl acyl carrier protein synthase | 0.0288 | 1 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0023 | 0.0427 | 0.007 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0013 | 0.0065 | 0.0065 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.01 | 0.3212 | 0.2993 |
Entamoeba histolytica | protein kinase, putative | 0.0022 | 0.036 | 1 |
Echinococcus multilocularis | serine threonine protein kinase nrc serine threonine protein kinase gad | 0.0013 | 0.0066 | 0.0049 |
Trichomonas vaginalis | AGC family protein kinase | 0.0022 | 0.036 | 0.5 |
Mycobacterium leprae | 3-oxoacyl-[acyl-carrier-protein] synthase 2 KasB (BETA-KETOACYL-ACP SYNTHASE) (KAS I) | 0.0188 | 0.6366 | 1 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.01 | 0.3212 | 0.3168 |
Trichomonas vaginalis | AGC family protein kinase | 0.0022 | 0.036 | 0.5 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0025 | 0.0487 | 0.0487 |
Echinococcus granulosus | sodium:potassium dependent atpase beta subunit | 0.0013 | 0.0061 | 0.0044 |
Loa Loa (eye worm) | AGC/AKT protein kinase | 0.0022 | 0.036 | 0.036 |
Echinococcus multilocularis | lamin dm0 | 0.0025 | 0.0487 | 0.0471 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.01 | 0.3212 | 1 |
Plasmodium falciparum | 3-oxoacyl-acyl-carrier protein synthase I/II | 0.0288 | 1 | 1 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0015 | 0.0114 | 0.0005 |
Toxoplasma gondii | AMP-binding enzyme domain-containing protein | 0.01 | 0.3212 | 0.2993 |
Trypanosoma brucei | beta-ketoacyl-ACP synthase | 0.0288 | 1 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0022 | 0.036 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0032 | 0.0726 | 0.0666 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0046 | 0.1258 | 0.1258 |
Trichomonas vaginalis | AGC family protein kinase | 0.0022 | 0.036 | 0.5 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0023 | 0.0427 | 0.0119 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.3212 | 0.3212 |
Loa Loa (eye worm) | hypothetical protein | 0.0015 | 0.011 | 0.011 |
Echinococcus granulosus | Glutaredoxin protein 5 | 0.0013 | 0.0061 | 0.0044 |
Trypanosoma cruzi | Protein kinase B | 0.0015 | 0.0114 | 0.0049 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.047 | 0.047 |
Brugia malayi | p70 ribosomal S6 kinase beta | 0.002 | 0.0312 | 0.0249 |
Schistosoma mansoni | hypothetical protein | 0.0158 | 0.5288 | 0.5236 |
Mycobacterium ulcerans | 3-oxoacyl-(acyl carrier protein) synthase II | 0.0288 | 1 | 1 |
Entamoeba histolytica | PH domain containing protein kinase, putative | 0.0015 | 0.0114 | 0.164 |
Echinococcus multilocularis | musashi | 0.0025 | 0.0487 | 0.0471 |
Echinococcus multilocularis | sodium:potassium dependent atpase beta subunit | 0.0013 | 0.0061 | 0.0044 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.011 | 0.0093 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0726 | 0.0624 |
Echinococcus granulosus | lamin | 0.0025 | 0.0487 | 0.0471 |
Schistosoma mansoni | hypothetical protein | 0.0045 | 0.1203 | 0.1106 |
Echinococcus multilocularis | nervana 2 | 0.0013 | 0.0061 | 0.0044 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0046 | 0.1258 | 0.1201 |
Echinococcus multilocularis | rac serine:threonine kinase | 0.0015 | 0.0114 | 0.0098 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0015 | 0.011 | 0.0093 |
Trypanosoma cruzi | beta-ketoacyl synthase family protein, putative | 0.0288 | 1 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-(acyl carrier protein) synthase II | 0.0288 | 1 | 1 |
Echinococcus multilocularis | nervana 2 | 0.0013 | 0.0061 | 0.0044 |
Loa Loa (eye worm) | AGC/RSK/P70 protein kinase | 0.002 | 0.0312 | 0.0312 |
Echinococcus multilocularis | lamin | 0.0025 | 0.0487 | 0.0471 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0045 | 0.1203 | 0.1146 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.1258 | 0.1258 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0487 | 0.0487 |
Echinococcus granulosus | nervana 2 | 0.0013 | 0.0061 | 0.0044 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.011 | 0.0093 |
Mycobacterium leprae | 3-oxoacyl-[acyl-carrier-protein] synthase 1 KasA (BETA-KETOACYL-ACP SYNTHASE) (KAS I) | 0.0188 | 0.6366 | 1 |
Trypanosoma cruzi | beta-ketoacyl synthase family protein, putative | 0.0288 | 1 | 1 |
Echinococcus granulosus | serine/threonine protein kinase | 0.0015 | 0.0114 | 0.0098 |
Giardia lamblia | Kinase, AGC PKA | 0.0013 | 0.0066 | 0.5 |
Plasmodium vivax | 3-oxoacyl-[acyl-carrier-protein] synthase i/ii, putative | 0.0288 | 1 | 1 |
Schistosoma mansoni | lamin | 0.0025 | 0.0487 | 0.0381 |
Toxoplasma gondii | 3-oxoacyl-acyl-carrier protein synthase I/II, putative | 0.0288 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0015 | 0.0126 | 0.0062 |
Loa Loa (eye worm) | hypothetical protein | 0.0012 | 0.0017 | 0.0017 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0015 | 0.011 | 0.0045 |
Echinococcus granulosus | geminin | 0.0158 | 0.5288 | 0.528 |
Echinococcus granulosus | calcium:calmodulin dependent protein kinase | 0.0013 | 0.0066 | 0.0049 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0015 | 0.011 | 0.0045 |
Loa Loa (eye worm) | beta-ketoacyl synthase domain-containing protein | 0.0288 | 1 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0023 | 0.0427 | 0.0364 |
Brugia malayi | intermediate filament protein | 0.0025 | 0.0487 | 0.0425 |
Loa Loa (eye worm) | hypothetical protein | 0.01 | 0.3212 | 0.3212 |
Entamoeba histolytica | protein kinase, putative | 0.002 | 0.0312 | 0.836 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0046 | 0.1258 | 0.1201 |
Trypanosoma cruzi | rac serine-threonine kinase, putative | 0.0015 | 0.0114 | 0.0049 |
Echinococcus multilocularis | 3 oxoacyl (acyl carrier protein) synthase | 0.0288 | 1 | 1 |
Echinococcus granulosus | intermediate filament protein | 0.0025 | 0.0487 | 0.0471 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier protein] synthase 1 KasA (beta-ketoacyl-ACP synthase) (KAS I) | 0.0188 | 0.6366 | 1 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier protein] synthase 2 KasB (beta-ketoacyl-ACP synthase) (KAS I) | 0.0188 | 0.6366 | 1 |
Echinococcus multilocularis | geminin | 0.0158 | 0.5288 | 0.528 |
Schistosoma mansoni | serine/threonine-protein kinase | 0.0015 | 0.0114 | 0.0005 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0015 | 0.011 | 0.0093 |
Echinococcus granulosus | GPCR family 2 | 0.0015 | 0.011 | 0.0093 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0023 | 0.0427 | 0.0364 |
Schistosoma mansoni | lamin | 0.0025 | 0.0487 | 0.0381 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0015 | 0.011 | 0.011 |
Brugia malayi | hypothetical protein | 0.022 | 0.7547 | 0.7531 |
Trichomonas vaginalis | AGC family protein kinase | 0.0022 | 0.036 | 0.5 |
Schistosoma mansoni | intermediate filament proteins | 0.0025 | 0.0487 | 0.0381 |
Trichomonas vaginalis | AGC family protein kinase | 0.0022 | 0.036 | 0.5 |
Schistosoma mansoni | survival motor neuron protein | 0.0045 | 0.1203 | 0.1106 |
Echinococcus granulosus | serine threonine protein kinase nrc | 0.0013 | 0.0066 | 0.0049 |
Leishmania major | beta-ketoacyl synthase family protein, putative,3-oxoacyl-acyl carrier protein synthase ii, putative | 0.0288 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0158 | 0.5288 | 0.5236 |
Onchocerca volvulus | 0.01 | 0.3212 | 1 | |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.01 | 0.3212 | 0.2993 |
Loa Loa (eye worm) | hypothetical protein | 0.022 | 0.7547 | 0.7547 |
Echinococcus multilocularis | Glutaredoxin protein 5 | 0.0013 | 0.0061 | 0.0044 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.